The Effect of Education and Telephone Follow-up Intervention Based on the Roy Adaptation Model

Sponsor
Akdeniz University (Other)
Overall Status
Completed
CT.gov ID
NCT03771937
Collaborator
(none)
66
2
17.7

Study Details

Study Description

Brief Summary

In this parallel randomized controlled trial (n = 33/group), the control group received routine care, while the intervention group received a telephone follow-up intervention, which consisted of a pre-discharge education program and three telephone follow-up sessions based on the Roy Adaptation Model.

Condition or Disease Intervention/Treatment Phase
  • Other: Education and telephone follow-up intervention
N/A

Detailed Description

Objective: To evaluate the effect of education and telephone follow-up intervention based on the Roy Adaptation Model (RAM) for improving MI patients' self-efficacy, quality of life and lifestyle adaptation.

Methods: In this parallel randomized controlled trial (n = 33/group), the control group received routine care, while the intervention group received a telephone follow-up intervention, which consisted of a pre-discharge education program and three telephone follow-up sessions based on the RAM. Data were collected before discharge, and in the 12th week after discharge included quality of life, coping adaptation process, self-efficacy and lifestyle changes.

Study Design

Study Type:
Interventional
Actual Enrollment :
66 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Masking Description:
Single blinding was provided that included inclusion criteria and agreement to participate in the study
Primary Purpose:
Prevention
Official Title:
The Effect of Education and Telephone Follow-up Intervention Based on the Roy Adaptation Model After Myocardial Infarction: a Randomized Controlled Trial
Actual Study Start Date :
Apr 3, 2016
Actual Primary Completion Date :
Aug 25, 2017
Actual Study Completion Date :
Sep 25, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

Intervention group received a telephone follow-up intervention, which consisted of a pre-discharge education program and three telephone follow-up sessions based on the RAM.

Other: Education and telephone follow-up intervention
A telephone follow up and a pre-discharge education

No Intervention: Control group

the control group received routine care.

Outcome Measures

Primary Outcome Measures

  1. General Self-Efficacy Scale [12 week]

    The self-efficacy levels of the patients were measured by the General Self-Efficacy Scale (GSES). The GSES contains 10 items and each item score ranges from 0 to 5. Cronbach's α of the GSES was 0.83. The highest and lowest possible score is between 10-40. High score indicates that the individual perceives high self-efficacy.

  2. Coping and Adaptation scale [12 week]

    To evaluate the coping and adaptation processes, the Coping and Adaptation (CAPS) scale was used. The CAPS was developed by Callista Roy. The Turkish validity and reliability study of the scale was conducted by Çatal and Dicle (2015), and the Cronbach alpha value was 0.82 for the total scale. The highest and lowest possible score is between 47-188. Higher scores indicate better use of effective coping methods.

  3. Myocardial Infarction Dimensional Assessment Scale [12 week]

    To evaluate the quality of life after the disease, the Myocardial Infarction Dimensional Assessment Scale (MIDAS) was used. This was developed by Thompson et al. in 2002. The Cronbach alpha values of the scale were found in seven dimensions, and ranged from 0.74 to 0.95, showing it to be a useful and highly reliable tool. The validity and reliability study of the scale was made by Yilmaz et al. Cronbach alpha values ranged from 0.79 to 0.90. The 10 highest and lowest possible score is between 0-100, with 0 indicating the best health condition, and 100 indicating the worst health condition.

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Participants were adults aged ≥30 years and had been admitted to the hospital with a diagnosis of MI (which must be supported by ECG and an increase in biomarkers).

  2. were clinically stable

  3. willing to participate

  4. able to understand and write Turkish

  5. able to receive telephone calls or fill in questionnaires.

  6. able to come to the hospital for checkups. Exclusion Criteria:Patients were excluded from the study if according to medical file records they had chronic renal failure, cancer, heart failure, severe aortic stenosis, if they were planned for surgical treatment or had chronic cognitive and psychiatric disease, if they had problems with hearing and speaking on the phone, or if they had mobility restriction.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Akdeniz University

Investigators

  • Principal Investigator: Selma Turan Kavradım, PhD, Akdeniz University Nursing Faculty
  • Study Director: Zeynep Canlı ÖZER, Professor, Akdeniz University Nursing Faculty

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Akdeniz University
ClinicalTrials.gov Identifier:
NCT03771937
Other Study ID Numbers:
  • 0001
First Posted:
Dec 11, 2018
Last Update Posted:
Dec 27, 2018
Last Verified:
Dec 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Akdeniz University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 27, 2018